A multimodal sleep foundation model based on polysomnography data can predict the risk for multiple conditions.

After metabolic bariatric surgery for obesity, 69.5 percent of patients demonstrated improvement or remission of psoriasis. HealthDay News — Metabolic bariatric surgery (MBS) is associated with ...

FDA requests removal of suicidal ideation warnings from GLP-1 RA labels after meta-analysis shows no increased risk compared with placebo.

A new report presents cardiovascular statistics in the United States, including five major cardiovascular risk factors.

Data from NHANES reveal a 43% increase in heart failure prevalence over 35 years, though age-standardized rates remained relatively stable.

More than one-quarter of adults aged 25 to 64 years from 99 countries are eligible to receive a GLP-1 receptor agonist.

Maternal influenza, Tdap vaccinations associated with lower risk for hospitalization or ED visits in infants younger than 6 ...

Novo Nordisk announced the availability of Wegovy tablets, the first oral GLP-1 receptor agonist for weight loss and CV risk ...

An AHA scientific statement examines the link between periodontal disease and ASCVD, highlighting shared risk factors and inflammatory mechanisms.

The FDA approved a new safety warning for Depo-Provera alerting patients to a possible risk for a type of brain tumor called ...